StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
AFYA$14.52+3.64%
Fair $14.52+0.0%

AFYA

Afya Limited

Consumer Defensive / Education & Training ServicesNasdaqGS

$14.52

+0.51 (+3.64%)

Fairly Valued+0.0%Fair Value $14.52Fund rank 39/100 · Data gapFallback financials|
SA 64/B
F-Score: 8/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 23% · confianza 25%

FCF escenarios

weak_data · normalized FCF $1.0B · quality 81.3/100

Data gap 39/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 92/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

64/100

B

Piotroski

8/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · AFYALocal privado en este navegador · Afya Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.3B

P/E

8.9x

↓

EV/EBITDA

2.0x

↓

ROE

15.5%

↑

Gross Margin

64.5%

↑

Debt/Equity

0.64

↑
52-Week Range$15
$13$19

TradingView lightweight chart

AFYA price, volumen y niveles de valoración

Último $14.52Periodo -39.1%
Fair value: $14.52

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+16.7%

FCF CAGR

+28.8%

FCF margin

31.6%

FCF / Net income

1.55x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $3.70B · net income $752.5M · FCF $1.17B

2022-FY → 2025-FY

Gross margin

64.5%+1.4% pts

Operating margin

32.8%+4.3% pts

Net margin

20.4%+4.3% pts

FCF margin

31.6%+8.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$3.70B$3.70B$3.30B$2.88B$2.33B
Net Income$752.5M$752.5M$631.5M$386.3M$373.6M
EBITDA$1.67B$1.67B$1.38B$1.11B$923.3M
EPS8.248.246.934.274.12
Gross Margin64.5%64.5%63.2%61.4%63.1%
Operating Margin32.8%32.8%30.6%26.7%28.5%
Net Margin20.4%20.4%19.1%13.4%16.0%
Balance Sheet
Debt/Equity0.640.640.740.740.85
Current Ratio1.781.78———
Cash Flow
Free Cash Flow$1.17B$1.17B$1.04B$798.2M$546.9M
Returns
ROE15.5%15.5%14.8%10.7%11.7%
Valuation
P/E8.858.852.164.883.49
EV/EBITDA1.981.982.643.633.16
P/B0.270.270.320.520.40
Growth & Yield
Revenue Growth11.9%11.9%14.9%23.5%—
EPS Growth18.9%18.9%62.3%3.6%—
Dividend Yield4.7%4.7%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-46.1%

fácil

EPS terminal req.

$1.29

Spread vs growth

65.0%

5Y implied EPS CAGR

-28.3%

fácil

EPS terminal req.

$1.56

Spread vs growth

47.2%

10Y implied EPS CAGR

-11.2%

fácil

EPS terminal req.

$2.51

Spread vs growth

30.1%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -15.7%

Total return

-15.7%

Start / end P/E

2.6x → 1.8x

EPS bridge

6.93 → 8.24

Residual

-6.2%

EPS growth+18.9%
Multiple rerating-33.0%
Dividend+4.7%
Residual / FX / buybacks / cross-term-6.2%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.